Clinical features and outcomes of invasive pneumococcal disease in a pediatric intensive care unit

BMC Pediatrics

Shao-Hsuan Hsia⁵  I-Jun Chou¹  Oi-Wa Chan⁵  I-Anne Huang⁶  Jainn-Jim Lin⁵  Yhu-Chering Huang³  Cheng-Hsun Chiu²  Jing-Long Huang⁴  Chang-Teng Wu¹  Hsiang-Ju Hsiao⁶ 

[1] Division of General Pediatrics, Department of Pediatrics, Chang Gung Memorial Hospital, Linkou, Taiwan;Molecular Infectious Disease Research Center, Division of Pediatric Infection, Chang Gung Memorial Hospital, Linkou, Taiwan;Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Linkou, Taiwan;Division of Asthma, Allergy, and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital, Linkou, Taiwan;Division of Pediatric Critical Care Medicine, Department of Pediatrics, Chang Gung Memorial Hospital, Linkou, Taiwan;Chang Gung University College of Medicine, Taoyuan, Taiwan

关键词: Streptococcus pneumoniae;    F;    serotype 19 ;    pneumococcal conjugate vaccine;    pediatric intensive care unit;    mortality;    invasive pneumococcal disease;    herd immunity;    Hemolytic uremic syndrome (HUS);   

Others  :  1221260
DOI  :  10.1186/s12887-015-0387-7

 received in 2014-12-11, accepted in 2015-05-27,  发布年份 2015

【 摘 要 】

Background

Invasive pneumococcal disease (IPD) results in high morbidity and mortality globally each year, although it is a vaccine-preventable disease. This study aimed to characterize the clinical features of IPD in a pediatric intensive care unit (PICU) in Taiwan. The seven-valent pneumococcal conjugate vaccine (PCV7) was introduced in the private sector in October 2005. The estimated coverage rate of PCV7 vaccination in 2010 was 45.5 % among children <5 years of age.

Methods

We conducted a retrospective study at a single center in northern Taiwan for invasive pneumococcal disease in a PICU from 2009 to 2013. Demographic characteristics, clinical courses, serotype, antibiotic susceptibility, and outcomes were analyzed.

Results

Over the 5-year study period, 2167 patients were admitted to the PICU; 48 (2.2 %) had IPD. There were 29 female and 19 male patients. Their mean age was 3.7 years (range 0.7–12.5 years, with the peak age at 2–5 years; n = 30, 63 %). Pneumonia was the most frequent type (n = 38, 79 %), followed by meningitis (n = 10, 21 %). In total, three patients died, all within 72 h after admission; the final diagnoses were all meningitis. Thirty-four children with pneumonia received chest tube insertion for pleural effusion drainage. Of them, 22 (65 %) finally still underwent video-assisted thoracoscopic surgery. Eight (17 %) children had hemolytic uremic syndrome, and seven of them underwent hemodialysis. In total, 37 serotypes were detected; 95 % were covered by PCV13. Serotype 19A was most common (54 %) overall; however, in those with meningitis, serotype 19 F was most common.

Conclusions

Meningitis is the most severe type of invasive pneumococcal disease in our pediatric intensive care unit. It may progress rapidly even when subjects are given antibiotics promptly. The most common serotype in meningitis is 19 F, which is vaccine preventable. Thus, universal mass pneumococcal vaccination is still needed.

【 授权许可】

   
2015 Hsiao et al.

【 参考文献 】

• [1]Hsieh YC, Lee WS, Shao PL, Chang LY, Huang LM. Transforming Streptococcus pneumoniae in the 21st century. Chang Gung Med J. 2008; 31(2):117-124.
• [2]O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N et al.. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009; 374(9693):893-902.
• [3]Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, Craig AS et al.. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009; 360(3):244-256.
• [4]Hampton LM, Zell ER, Schrag S, Cohen AL. Sentinel versus population-based surveillance of pneumococcal conjugate vaccine effectiveness. Bull World Health Organ. 2012; 90(8):568-577.
• [5]Leal J, Vanderkooi OG, Church DL, Macdonald J, Tyrrell GJ, Kellner JD. Eradication of invasive pneumococcal disease due to the seven-valent pneumococcal conjugate vaccine serotypes in Calgary. Alberta. Pediatr Infect Dis J. 2012; 31(9):e169-175.
• [6]Chiang CS, Chen YY, Jiang SF, Liu DP, Kao PH, Teng HJ et al.. National surveillance of invasive pneumococcal diseases in Taiwan, 2008–2012: differential temporal emergence of serotype 19A. Vaccine. 2014; 32(27):3345-3349.
• [7]Wei SH, Chiang CS, Chiu CH, Chou P, Lin TY. Pediatric invasive pneumococcal disease in Taiwan following a national catch-up program with the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2015; 34(3):e71-77.
• [8]Thigpen MC, Whitney CG, Messonnier NE, Zell ER, Lynfield R, Hadler JL et al.. Bacterial meningitis in the United States, 1998–2007. N Engl J Med. 2011; 364(21):2016-2025.
• [9]Beers SR, Wisniewski SR, Garcia-Filion P, Tian Y, Hahner T, Berger RP et al.. Validity of a pediatric version of the Glasgow outcome scale-extended. J Neurotrauma. 2012; 29(6):1126-1139.
• [10]Paulke-Korinek M, Kollaritsch H, Kundi M, Schmidle-Loss B, Zwazl I, Laaber B et al.. Characteristics of invasive pneumococcal disease in hospitalized children in Austria. Eur J Pediatr. 2014; 173(4):469-476.
• [11]Shen CF, Wang SM, Lee KH, Ho TS, Liu CC. Childhood invasive pneumococcal disease caused by non-7-valent pneumococcal vaccine (PCV7) serotypes under partial immunization in Taiwan. J Formos Med Assoc. 2013; 112(9):561-568.
• [12]Copelovitch L, Kaplan BS. Streptococcus pneumoniae-associated hemolytic uremic syndrome: classification and the emergence of serotype 19A. Pediatrics. 2010; 125(1):e174-182.
• [13]Huang YH, Lin TY, Wong KS, Huang YC, Chiu CH, Lai SH et al.. Hemolytic uremic syndrome associated with pneumococcal pneumonia in Taiwan. Eur J Pediatr. 2006; 165(5):332-335.
• [14]Chen SY, Wu CY, Tsai IJ, Tsau YK, Su YT. Nonenteropathic hemolytic uremic syndrome: the experience of a medical center. Pediatr Neonatol. 2011; 52(2):73-77.
• [15]Lee CS, Chen MJ, Chiou YH, Shen CF, Wu CY, Chiou YY. Invasive pneumococcal pneumonia is the major cause of paediatric haemolytic-uraemic syndrome in Taiwan. Nephrology (Carlton). 2012; 17(1):48-52.
• [16]Janapatla RP, Hsu MH, Hsieh YC, Lee HY, Lin TY, Chiu CH. Necrotizing pneumonia caused by nanC-carrying serotypes is associated with pneumococcal haemolytic uraemic syndrome in children. Clin Microbiol Infect. 2013; 19(5):480-486.
• [17]Banerjee R, Hersh AL, Newland J, Beekmann SE, Polgreen PM, Bender J et al.. Streptococcus pneumoniae-associated hemolytic uremic syndrome among children in North America. Pediatr Infect Dis J. 2011; 30(9):736-739.
• [18]van de Beek D, Brouwer MC, Thwaites GE, Tunkel AR. Advances in treatment of bacterial meningitis. Lancet. 2012; 380(9854):1693-1702.
• [19]Kanegaye JT, Soliemanzadeh P, Bradley JS. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics. 2001; 108(5):1169-1174.
• [20]Radetsky M. Fulminant bacterial meningitis. Pediatr Infect Dis J. 2014; 33(2):204-207.
• [21]Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain. 2003; 126(5):1015-1025.
• [22]Mook-Kanamori BB, Geldhoff M, van der Poll T, van de Beek D. Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev. 2011; 24(3):557-591.
• [23]Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2013; 6:CD004405.
• [24]Grabenstein JD, Musey LK. Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults. Vaccine. 2014; 32(21):2399-2405.
• [25]Kuo CY, Hwang KP, Hsieh YC, Cheng CH, Huang FL, Shen YH et al.. Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine. Vaccine. 2011; 29(32):5171-5177.
• [26]Gaschignard J, Levy C, Chrabieh M, Boisson B, Bost-Bru C, Dauger S et al.. Invasive pneumococcal disease in children can reveal a primary immunodeficiency. Clin Infect Dis. 2014; 59(2):244-251.